Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Rubella seroprevalence among pregnant women in Beijing, China

Authors: Qinghong Meng, Jie Luo, Lijun Li, Wei Shi, Jinqian Yu, Yingjie Shen, Li Li, Yajuan Wang, Kaihu Yao

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Rubella infection in pregnant women can result in serious effects, such as miscarriages, stillbirths, and congenital rubella syndrome (CRS). However, very little is known about the rubella seroprevalence among pregnant women in China.

Methods

This is a cross-sectional and hospital-based study. From June 2016 through March 2017, a total of 324 serum samples from healthy pregnant women were collected in the Shunyi Women and Children’s Hospital of Beijing Children’s Hospital. Rubella-specific IgG antibody was determined by ELISA (Euroimmun, Lübeck, Germany) kits. International assigned cut-off values of ≥10 IU/ml were used to assess the percentage of pregnant women with protective IgG concentrations.

Results

The total rate of protected individuals was 83.3% (95% CI: 78.9%–87.0%). The protective rates of pregnant women in 17–26 years group, 27–36 years group and 37–46 years group were 84.0% (95% CI: 75.3%–90.1%), 81.9% (95% CI: 74.9%–87.4%) and 84.9% (95% CI: 75.8%–90.9%) respectively. No significant difference in protective rates among the three age groups was found (P = 0.83). There were also no statistically significant correlations between protective rates and gravidity (P = 0.84), parity (P = 0.84), birth place (P = 0.16), residence area (P = 0.58), education (P = 0.40) or occupation (P = 0.65).

Conclusions

Despite the generally low vaccination coverage for rubella, most of Chinese pregnant women had potent rubella immunity. However, at least 16.7% of pregnant women were susceptible to rubella, which suggested rubella immunization in Chinese women at or before child-bearing age.
Literature
2.
go back to reference D'Agaro P, Dal Molin G, Zamparo E, Rossi T, Micuzzo M, Busetti M, Santon D, Campello C. Epidemiological and molecular assessment of a rubella outbreak in North-Eastern Italy. J Med Virol. 2010;82(11):1976–82.CrossRefPubMed D'Agaro P, Dal Molin G, Zamparo E, Rossi T, Micuzzo M, Busetti M, Santon D, Campello C. Epidemiological and molecular assessment of a rubella outbreak in North-Eastern Italy. J Med Virol. 2010;82(11):1976–82.CrossRefPubMed
3.
go back to reference Lazar M, Abernathy E, Chen MH, Icenogle J, Janta D, Stanescu A, Pistol A, Santibanez S, Mankertz A, Hubschen JM, et al. Epidemiological and molecular investigation of a rubella outbreak, Romania, 2011 to 2012. Euro Surveill. 2016;21(38):30345. Lazar M, Abernathy E, Chen MH, Icenogle J, Janta D, Stanescu A, Pistol A, Santibanez S, Mankertz A, Hubschen JM, et al. Epidemiological and molecular investigation of a rubella outbreak, Romania, 2011 to 2012. Euro Surveill. 2016;21(38):30345.
4.
go back to reference Miyoshi M, Komagome R, Ishida S, Nagano H, Okano M. Epidemiology and laboratory diagnoses of rubella in Hokkaido district during the nationwide outbreak in Japan, 2011-2013. Jpn J Infect Dis. 2014;67(6):479–84.CrossRefPubMed Miyoshi M, Komagome R, Ishida S, Nagano H, Okano M. Epidemiology and laboratory diagnoses of rubella in Hokkaido district during the nationwide outbreak in Japan, 2011-2013. Jpn J Infect Dis. 2014;67(6):479–84.CrossRefPubMed
5.
go back to reference Messedi E, Fki-Berrajah L, Gargouri S, Chouikha A, Chaari A, Bouaziz M, Jallouli H, Yahia AB, Hammami A, Triki H, et al. Clinical epidemiological and molecular aspects of rubella outbreak with high number of neurological cases, Tunisia 2011-2012. J Clin Virol. 2014;61(2):248–54.CrossRefPubMed Messedi E, Fki-Berrajah L, Gargouri S, Chouikha A, Chaari A, Bouaziz M, Jallouli H, Yahia AB, Hammami A, Triki H, et al. Clinical epidemiological and molecular aspects of rubella outbreak with high number of neurological cases, Tunisia 2011-2012. J Clin Virol. 2014;61(2):248–54.CrossRefPubMed
6.
go back to reference Andrus JK, de Quadros CA, Solorzano CC, Periago MR, Henderson DA. Measles and rubella eradication in the Americas. Vaccine. 2011;29(Suppl 4):D91–6.CrossRefPubMed Andrus JK, de Quadros CA, Solorzano CC, Periago MR, Henderson DA. Measles and rubella eradication in the Americas. Vaccine. 2011;29(Suppl 4):D91–6.CrossRefPubMed
7.
go back to reference Grangeot-Keros L, Bouthry E, Vauloup-Fellous C. Rubella: a current issue? Presse Med. 2014;43(6 Pt 1):698–705.CrossRefPubMed Grangeot-Keros L, Bouthry E, Vauloup-Fellous C. Rubella: a current issue? Presse Med. 2014;43(6 Pt 1):698–705.CrossRefPubMed
8.
go back to reference Sugishita Y, Shimatani N, Katow S, Takahashi T, Hori N. Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012-2013 epidemics in Tokyo, Japan. Jpn J Infect Dis. 2015;68(2):159–65.CrossRefPubMed Sugishita Y, Shimatani N, Katow S, Takahashi T, Hori N. Epidemiological characteristics of rubella and congenital rubella syndrome in the 2012-2013 epidemics in Tokyo, Japan. Jpn J Infect Dis. 2015;68(2):159–65.CrossRefPubMed
10.
go back to reference Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(5):136–8.CrossRefPubMedPubMedCentral Kim DK, Riley LE, Harriman KH, Hunter P, Bridges CB. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(5):136–8.CrossRefPubMedPubMedCentral
11.
go back to reference Zhu Z, Cui A, Wang H, Zhang Y, Liu C, Wang C, Zhou S, Chen X, Zhang Z, Feng D, et al. Emergence and continuous evolution of genotype 1E rubella viruses in China. J Clin Microbiol. 2012;50(2):353–63.CrossRefPubMedPubMedCentral Zhu Z, Cui A, Wang H, Zhang Y, Liu C, Wang C, Zhou S, Chen X, Zhang Z, Feng D, et al. Emergence and continuous evolution of genotype 1E rubella viruses in China. J Clin Microbiol. 2012;50(2):353–63.CrossRefPubMedPubMedCentral
12.
go back to reference Zhu Z, Xu W, Abernathy ES, Chen MH, Zheng Q, Wang T, Zhang Z, Li C, Wang C, He W, et al. Comparison of four methods using throat swabs to confirm rubella virus infection. J Clin Microbiol. 2007;45(9):2847–52.CrossRefPubMedPubMedCentral Zhu Z, Xu W, Abernathy ES, Chen MH, Zheng Q, Wang T, Zhang Z, Li C, Wang C, He W, et al. Comparison of four methods using throat swabs to confirm rubella virus infection. J Clin Microbiol. 2007;45(9):2847–52.CrossRefPubMedPubMedCentral
13.
go back to reference Chen M, Zhu Z, Liu D, Huang G, Huang F, Wu J, Zhang T, Xu W, Pang X. Rubella epidemic caused by genotype 1E rubella viruses in Beijing, China, in 2007-2011. Virol J. 2013;10:122.CrossRefPubMedPubMedCentral Chen M, Zhu Z, Liu D, Huang G, Huang F, Wu J, Zhang T, Xu W, Pang X. Rubella epidemic caused by genotype 1E rubella viruses in Beijing, China, in 2007-2011. Virol J. 2013;10:122.CrossRefPubMedPubMedCentral
14.
go back to reference Wang C, Zhu Z, Xu Q, Xu A, Fang X, Song L, Li W, Xiong P, Xu W. Rubella epidemics and genotypic distribution of the rubella virus in Shandong Province, China, in 1999-2010. PLoS One. 2012;7(7):e42013.CrossRefPubMedPubMedCentral Wang C, Zhu Z, Xu Q, Xu A, Fang X, Song L, Li W, Xiong P, Xu W. Rubella epidemics and genotypic distribution of the rubella virus in Shandong Province, China, in 1999-2010. PLoS One. 2012;7(7):e42013.CrossRefPubMedPubMedCentral
15.
go back to reference Xu Q, Xu AQ, Song LZ, Wang CY, Zhang L, Xiao ZK, Li WX, Xiong P. Retrospective epidemiologic investigation on congenital rubella syndrome in monitoring region of Shandong province, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2010;31(7):828–9.PubMed Xu Q, Xu AQ, Song LZ, Wang CY, Zhang L, Xiao ZK, Li WX, Xiong P. Retrospective epidemiologic investigation on congenital rubella syndrome in monitoring region of Shandong province, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2010;31(7):828–9.PubMed
16.
go back to reference Calimeri S, Capua A, La Fauci V, Squeri R, Grillo OC, Lo Giudice D. Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy. Int J Gynaecol Obstet. 2012;116(3):211–3.CrossRefPubMed Calimeri S, Capua A, La Fauci V, Squeri R, Grillo OC, Lo Giudice D. Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy. Int J Gynaecol Obstet. 2012;116(3):211–3.CrossRefPubMed
17.
go back to reference Tahita MC, Hubschen JM, Tarnagda Z, Ernest D, Charpentier E, Kremer JR, Muller CP, Ouedraogo JB. Rubella seroprevalence among pregnant women in Burkina Faso. BMC Infect Dis. 2013;13:164.CrossRefPubMedPubMedCentral Tahita MC, Hubschen JM, Tarnagda Z, Ernest D, Charpentier E, Kremer JR, Muller CP, Ouedraogo JB. Rubella seroprevalence among pregnant women in Burkina Faso. BMC Infect Dis. 2013;13:164.CrossRefPubMedPubMedCentral
18.
go back to reference Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012. Vaccine. 2013;32(1):69–73.CrossRefPubMed Fitter DL, Anselme R, Paluku G, Rey G, Flannery B, Tohme RA, Marston BJ, Griswold M, Boncy J, Vertefeuille JF. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012. Vaccine. 2013;32(1):69–73.CrossRefPubMed
19.
go back to reference Olajide OM, Aminu M, Randawa AJ, Adejo DS. Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria. Int J Womens Health. 2015;7:75–83.PubMedPubMedCentral Olajide OM, Aminu M, Randawa AJ, Adejo DS. Seroprevalence of rubella-specific IgM and IgG antibodies among pregnant women seen in a tertiary hospital in Nigeria. Int J Womens Health. 2015;7:75–83.PubMedPubMedCentral
20.
go back to reference Alvarado-Esquivel C, Hernandez-Tinoco J, Sanchez-Anguiano LF, Ramos-Nevarez A, Cerrillo-Soto SM, Salas-Pacheco JM, Sandoval-Carrillo AA, Martinez-Ramirez L, Antuna-Salcido EI, Guido-Arreola CA. Rubella immune status in pregnant women in a northern Mexican City. J Clin Med Res. 2016;8(9):656–61.CrossRefPubMedPubMedCentral Alvarado-Esquivel C, Hernandez-Tinoco J, Sanchez-Anguiano LF, Ramos-Nevarez A, Cerrillo-Soto SM, Salas-Pacheco JM, Sandoval-Carrillo AA, Martinez-Ramirez L, Antuna-Salcido EI, Guido-Arreola CA. Rubella immune status in pregnant women in a northern Mexican City. J Clin Med Res. 2016;8(9):656–61.CrossRefPubMedPubMedCentral
21.
go back to reference Jonas A, Cardemil CV, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr, Sawadogo S, Patel SV, Zeko S, et al. Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010. Int J Infect Dis. 2016;49:196–201.CrossRefPubMed Jonas A, Cardemil CV, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr, Sawadogo S, Patel SV, Zeko S, et al. Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010. Int J Infect Dis. 2016;49:196–201.CrossRefPubMed
22.
go back to reference Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, Acharya G. Rubella virus immunization status in preconception period among Chinese women of reproductive age: a nation-wide, cross-sectional study. Vaccine. 2017;35(23):3076–81.CrossRefPubMed Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, Acharya G. Rubella virus immunization status in preconception period among Chinese women of reproductive age: a nation-wide, cross-sectional study. Vaccine. 2017;35(23):3076–81.CrossRefPubMed
23.
go back to reference Kolawole OM, Anjorin EO, Adekanle DA, Kolawole CF, Durowade KA. Seroprevalence of rubella IgG antibody in pregnant women in osogbo, Nigeria. Int J Prev Med. 2014;5(3):287–92.PubMedPubMedCentral Kolawole OM, Anjorin EO, Adekanle DA, Kolawole CF, Durowade KA. Seroprevalence of rubella IgG antibody in pregnant women in osogbo, Nigeria. Int J Prev Med. 2014;5(3):287–92.PubMedPubMedCentral
24.
go back to reference Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol. 1996;106(2):170–4.CrossRefPubMed Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol. 1996;106(2):170–4.CrossRefPubMed
25.
go back to reference van den Berg JP, Westerbeek EA, Smits GP, van der Klis FR, Berbers GA, van Elburg RM. Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants. PLoS One. 2014;9(4):e94714.CrossRefPubMedPubMedCentral van den Berg JP, Westerbeek EA, Smits GP, van der Klis FR, Berbers GA, van Elburg RM. Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants. PLoS One. 2014;9(4):e94714.CrossRefPubMedPubMedCentral
26.
go back to reference Sugishita Y, Takahashi T, Hori N, Abo M. Ongoing rubella outbreak among adults in Tokyo, Japan, June 2012 to April 2013. Western Pac Surveill Response J. 2013;4(3):37–41.CrossRefPubMedPubMedCentral Sugishita Y, Takahashi T, Hori N, Abo M. Ongoing rubella outbreak among adults in Tokyo, Japan, June 2012 to April 2013. Western Pac Surveill Response J. 2013;4(3):37–41.CrossRefPubMedPubMedCentral
27.
go back to reference Centers for Disease C, Prevention. Progress toward the 2012 measles elimination goal--western Pacific region, 1990-2008. MMWR Morb Mortal Wkly Rep. 2009;58(24):669–73. Centers for Disease C, Prevention. Progress toward the 2012 measles elimination goal--western Pacific region, 1990-2008. MMWR Morb Mortal Wkly Rep. 2009;58(24):669–73.
29.
go back to reference De Paschale M, Manco MT, Paganini A, Agrappi C, Mirri P, Cucchi G, Saccani B, D'Arcais AF, Clerici P: Rubella antibody screening during pregnancy in an urban area of Northern Italy. Infect Dis Rep 2012, 4(1):e17. De Paschale M, Manco MT, Paganini A, Agrappi C, Mirri P, Cucchi G, Saccani B, D'Arcais AF, Clerici P: Rubella antibody screening during pregnancy in an urban area of Northern Italy. Infect Dis Rep 2012, 4(1):e17.
30.
go back to reference Lim GH, Harris T, Desai S, Crowcroft NS, Mazzulli T, Kozlowski T, Deeks SL. Rubella immunity among prenatal women in Ontario, 2006-2010. BMC Infect Dis. 2013;13:362.CrossRefPubMedPubMedCentral Lim GH, Harris T, Desai S, Crowcroft NS, Mazzulli T, Kozlowski T, Deeks SL. Rubella immunity among prenatal women in Ontario, 2006-2010. BMC Infect Dis. 2013;13:362.CrossRefPubMedPubMedCentral
32.
go back to reference Mou J, Griffiths SM, Fong HF, Hu Q, Xie X, He Y, Ma H, Cheng J. Seroprevalence of rubella in female migrant factory workers in Shenzhen, China. Vaccine. 2010;28(50):7844–51.CrossRefPubMed Mou J, Griffiths SM, Fong HF, Hu Q, Xie X, He Y, Ma H, Cheng J. Seroprevalence of rubella in female migrant factory workers in Shenzhen, China. Vaccine. 2010;28(50):7844–51.CrossRefPubMed
33.
go back to reference He H, Yan R, Tang X, Zhou Y, Deng X, Xie S. Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome. BMC Infect Dis. 2016;16:723.CrossRefPubMedPubMedCentral He H, Yan R, Tang X, Zhou Y, Deng X, Xie S. Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome. BMC Infect Dis. 2016;16:723.CrossRefPubMedPubMedCentral
Metadata
Title
Rubella seroprevalence among pregnant women in Beijing, China
Authors
Qinghong Meng
Jie Luo
Lijun Li
Wei Shi
Jinqian Yu
Yingjie Shen
Li Li
Yajuan Wang
Kaihu Yao
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3032-x

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.